Summit Therapeutics PLC (SMMT) earnings · $11.46B cap
These earnings events as JSON? API free 100/daySummit Therapeutics PLC (SMMT) is a biotechnology company listed on US.
This SMMT earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported SMMT revenue for 2024-12-31 was $0. Net income was -$221.3M. SMMT currently screens at market cap $11.46B.
When the next SMMT 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for SMMT. We will not invent a beat or miss.
Not investment advice. Full SMMT research stays on the stock page; the tape stays on the quote page.
SMMT earnings FAQ
What is SMMT's latest net income?
Latest cached Summit Therapeutics PLC (SMMT) net income was -$221.3M. Statements: https://lician.com/financials/smmt
What is SMMT's latest diluted EPS?
Latest cached Summit Therapeutics PLC (SMMT) diluted EPS for Dec 31, 2024 was -$0.31.
What period does the latest SMMT earnings print cover?
The latest cached Summit Therapeutics PLC (SMMT) earnings print covers Dec 31, 2024. The prior cached period on this page is Dec 31, 2023.
Where are SMMT earnings listed?
Cached earnings facts for Summit Therapeutics PLC (SMMT) are listed at https://lician.com/earnings/smmt. Statements: https://lician.com/financials/smmt
Not investment advice.